medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2002, Number 2

<< Back Next >>

Rev Med UV 2002; 2 (2)

Mycobacterium tuberculosis: Su pared celular y la utilidad diagnóstica de las proteínas 16 y 38 kDa

Ramírez RNA, Cocotle RBE, Méndez PA, Arenas BJ

Language: Spanish
References: 44
Page: 39-43
PDF size: 140.39 Kb.


Text Extraction

No abstract


REFERENCES

  1. Stewart S. Granulomatous reactions. En: Stewart S. et al. Immunology, immunopathology and immunity. 1996. 5a edición. Appleton and Lange USA. 467 – 471.

  2. Tuberculosis. Sociedad Iberoamericana de Información científica (SIIC). Consejo de Dirección. relacien@siicsalud.com. 1998.

  3. Behr MA, Wilson MA, Salamon H, gill WP, Schoolnik GK, Rane S, Small PM Science 1999; 284: 1520–1523.

  4. Chang Z, Primm TP. Jakan J, Lee IH, Serysheva I, Chiu W, Gilbert HF, Quiocho FA. Journal of biological chemistry. 271; 12:

  5. Chang z, Choudary A, Lathigra R, Quiocho FA Journal of Bioilogical Chamistry. 1994; 269; 21: 1956-58.

  6. Perskvist N, Zheng L, Stendahl O. The Journal of Immunology, 2000, 164: 959 – 965.

  7. Raman S, Song T,Puyang X, Bardarov S, Jacobs WR, Husson RN. Journal of Bacteriology. 2001; 183 (20): 6119 – 6125.

  8. Lowrie DB, Tascon RE, Bonato VL, Lima VM, Faccioli LH, Stavropoulos E, Coston JM, Hewinson RG. Nature. 1999; 400; 99: 269 – 271

  9. Cherrys JC. An introduction to infectious diseases. Elsevier. 1984: 698 – 701.

  10. Pitchenik AE, Fertel D. Tuberculosis and nontuberculous mycobacterium diseases. Med Clin North Am. 1992; 76: 121 – 171.

  11. Murray P. “Mycobacterium”. En: Murray P, et al. Manual of clinical microbiology. 1999. 17a edición. 370 – 421.

  12. Antonio GM, Martín N, Moreno S, Nogales MC. “Diagnostico microbiológico de las infecciones por micobacterias”. En: Recomendaciones de la sociedad Española de enfermedades infecciosas y Microbiología clínica. Procedimientos en microbiología clínica. 1999.

  13. Arredondo G, Calderón J. Conceptos clínicos de infectología. 1995, 10ª edición. Méndez Editores. México D.F. 225 – 233.

  14. Microbiología médica.

  15. Koneman W. “Mycobacterias”. En Koneman. Diagnóstico microbiológico. 1992. 3ª edición. Ed. Médica Panamericana. Buenos Aires. 62.

  16. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV. Nature. 1998. 93: 538 – 544.

  17. Bradley J, Mckluskey J. “Tuberculosis”. En: Bradley J, Mckluskey J. Clinical immunology. 1997. Oxford. Hong Kong. 189.

  18. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. Science 276:1420-1422

  19. Rose N. “Citokines and immune cells products”. Rose N, et al. Manual of clinical laboratory in immunology. 1997. 5a ed. USA. 536.

  20. Pospolevo LE. Tuberculosis impaction in various HLA phenotypes. Tubercule. 1990; 71: 187 – 192.

  21. Young RA. Stress proteins and immunology. Annu Rev Immunol. 1990; 8: 401 – 420.

  22. Young DD, Kauffman SH. Mycobacterial protein antigen. Mol Microbiol. 1992; 6: 133 – 145.

  23. Young D, Galve TR. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect Immun. 1991; 59: 3086 – 3093.

  24. Yang X, Gasser DJ, Feige U. Prevention of adjuvant arthritis in rats by a nonapeptid from 65 kDa Mycobacterial heat shock protein. Clin Exp Immunol. 1990; 81: 189 – 194.

  25. Lamb J, Bal P. Stress Protein may provide a link between the immune response to infection and autoimmunity. Int Immun. 1991; 121: 191 – 196.

  26. Peetermans WE, Raats IJ, van Furth R, Langermans AM. Infection and immunity, 1995,. 63; 9: 3454-3458.

  27. Jaatela M, Wissing D. J Exp Med. 177, 1993: 231 –36.

  28. Young DB, Garbe TR. Res Microbiol. 91, 142; 1: 55-65.

  29. Post FA, Manca C, Neyrolles O, Ryffel B, Young DB, Kaplan G. Infection and immunity. 2001, 69; 3: 1433-1439.

  30. Rees AD, Roman E, Moreno C. The effect of lipoylation on human epitope specific CD4 T-cell recognition of the 19 kDa mycobacterial antigen. Immunology. 1993; 80: 407-414.

  31. Content J, De Wit L. The genes coding for the antigen 85 complex of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning , sequence, determination, and genomic organization of the gene coding for the antigen 85-C of Mycobacterium tuberculosis. Infect Immun. 1991; 59: 3205-3212.

  32. Wiker HG, Harboe M. The antigen 85 complex: a majors secretion product of Mycobacterium tuberculosis. Microbiol Res. 1992;56:648-661.

  33. Rojas EO. “Desarrollo de inmunógenos y vacunas contra Lepra y Tuberculosis”. En: Cabrera CR. Vacunas. 2000. 249 – 260.

  34. Pérez TR. “Patología de las enfermedades infecciosas”. En Pérez TR. Principios de Patología. 1991. 3ª ed. México D.F. 325 – 329.

  35. Vordermeier HM, Harris DP, Roman E, Lathigra R, Moreno C, Ivany J. The Journal of Immunology, 1991; 147: 1023 – 1029

  36. Kadiva GB, Charapas SV, Hussong D. Characterization of serologic and cell–mediated reactivity of the 38 kDa antigen isolated from Mycobacterium tuberculosis. J Immunol. 1987; 139: 2447 – 2451.

  37. Daniel TM, Anderson PA. The isolation by immunoabsorbent affinity chromatrography and Physico chemical characterization of Mycobacterium tuberculosis antigen 5. Am Res Repir Dis. 1978; 117: 533 – 539.

  38. Xiaojiu Z, Stauss HJ, Ivanyi J, Vordermeier HM. International Immunology, 1997. 9; 11: 1669-1676.

  39. Gururaj VK, Sotiros DCh, Hussong D. Journal of immunology. 1987. 139; 7: 2447-2451.

  40. Harboe M, Wiker HG. The Journal of Infectious Diseases. 1992; 166: 874 – 884.

  41. Kadival GJ, Chaparas SD, Hussong D. The Journal of Immunology, 1987, 139: 2447 – 2451.

  42. Imaz MS, Bonifasich E, Diaz N, Claus JD, Singh M. Int J Tuberc Lung Dis. 2001, 5; 11: 1036-43.

  43. Quiocho F, Chag Z, Choudhary A. Cloning, overexpession and purification of 38 kDa y 16 kDa protein antigens of Mycobacterium tuberculosis (DCM20).

  44. Garbe TR; Hibler NS; Deretic V. Infect Imun. 1999;67; 1: 460-5.




2020     |     www.medigraphic.com